(Press-News.org) HOUSTON - (Jan. 10, 2011) – All fat cells are not the same – a fact that has implications in the understanding and treatment of type 2 diabetes and obesity, said researchers from Baylor College of Medicine (www.bcm.edu) in a report that appears in the current issue of the Journal of Cell Biology (http://www.jcb.rupress.org/).
The amount of fat in each cell and the central transcription factor, PPAR gamma (peroxisome proliferator activated receptor gamma), can vary widely, but the fat cells (adipocytes) can maintain stable levels of master switches known as steroid receptor coactivators (SRC)-2 and -3, said Dr. Sean M. Hartig, a postdoctoral fellow, and Dr. Michael Mancini (http://www.bcm.edu/mcb/?PMID=9330), an associate professor of molecular and cellular biology at BCM and the director of the Integrated Microscopy Core at BCM (http://www.bcm.edu/microscopy/). Hartig is first author and Mancini senior author of the report.
"The difference was the SRCs," said Hartig. "They control the transcriptional switch for PPAR gamma to maximize fat accumulation."
PPAR gamma is known to regulate the production of adipocytes or fat cells. It regulates transcription – making an RNA copy of DNA, which is the first step in gene expression.
"Our research shows that there isn't always a linear connection between this transcriptional regulator PPAR gamma and the lipid in a cell," said Mancini. "It's dogma that one equals the other, but as you dive into the population of cells using high throughput microscopy and with custom-built software 'pipelines,' you find lots of exceptions. Then Sean (Hartig) connected it to the coregulators."
New drug-screening technology that automates both microscopy and image analysis allows experts like Mancini and Hartig to collect pictures and quantify thousands of cells in a short period of time. In this case, it allowed them to analyze the composition of different populations of human fat cells.
"Sean measured the amount of lipid in every cell," said Mancini. "This new technology uses fluorescent dyes and antibodies and enabled him to quantify both the amount of fat in each cell, but also how much of the transcriptional regulator PPAR gamma was expressed."
"There was a continuum," said Hartig. "There were cells that did not have any PPAR gamma but still had somehow become adipocytes. There were cells that had increased levels of PPAR gamma but had never developed the characteristics of adipocytes."
The finding supports the theory that these cells represent a continuum of factors with modulated levels of PPAR gamma and lipids. "PPAR-equals-fat simply didn't hold up to this level of scrutiny," Mancini said.
Mancini pointed to a population of cells with high lipid levels and low levels of PPAR gamma. There were cells with the opposite situation.
Hartig said reduced levels of SRC-2 and 3 resulted in more cells with low levels of lipid and increased PPAR gamma.
This is important because some drugs used to treat type 2 diabetes increase the activity of PPAR gamma. These include the thiazolidines such as Actos and Avandia, which increase the levels of genes associated with sensitivity to insulin. However, because PPAR gamma stimulates fat cell production, these drugs can also lead to increased abdominal fat and, more recently, cardiovascular complications.
"If you could find a way to increase the proportion of cells that have PPAR gamma but don't accumulate lipids, you might have a positive outcome. That would probably require a drug with a different structure," said Mancini.
The automated microscopy makes it possible to monitor the effects of drugs on different populations of a large number of cells, said Mancini.
"Had we not been able to analyze the cell-to-cell differences, we would not necessarily have understood how this favorable switch controlling PPAR gamma transcriptional activity might manifest itself. Identification of compounds that target the SRC and PPAR gamma interface might be alternatives to current therapeutic strategies for type 2 diabetes," said Hartig.
###
Others who took part in this work include Bin He and Weiwen Long of BCM and Benjamin M. Fuehrer of Zen-Bio, Inc., in Research Triangle Park, N.C.
Funding for this work came from the National Institutes of Health, the Hankamer Foundation, the John S. Dunn Gulf Coast Consortium for Chemical Genomics (http://cohesion.rice.edu/centersandinst/gcc/gccddr.cfm) and the Dan L. Duncan Cancer Center (http://www.bcm.edu/cancercenter/) at BCM.
For more information on basic science research at Baylor College of Medicine, please go to From the Laboratories at Baylor College of Medicine (www.bcm.edu/fromthelab).
END
A new study found that there is a serious increased risk of side effects requiring hospitalization in people over the age of 65 who are going through latent tuberculosis infection therapy, according to a study published in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj091824.pdf.
Latent tuberculosis therapy has been shown to reduce the development of active tuberculosis (TB) disease and is used as a way to control tuberculosis in Canada and the United States. Deciding to treat a person with latent tuberculosis therapy ...
While the evidence is incomplete there is enough available to support legislation against letting people smoke in cars with children, states an article in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj100903.pdf.
This analysis was conducted to settle the matter of risk to children when in a car with second-hand smoke. The authors also wanted to show that although smoking in cars is not 23 times more toxic in a car than in a home it can still be very harmful to children.
"We hope to show that, though the relevant data ...
The use of recombinant activated factor 7 (rFVIIa) despite its potential for adverse events displays the serious shortcomings of Canada's current drug surveillance system, according to a commentary published in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj101842.pdf.
Off-label use of this therapy — a blood product — was driven by key physician opinion leaders who thought recombinant factor VIIa could be used to treat or prevent bleeding in patients without hemophilia at risk of death. This shows how promising case ...
A paper published online on January 10 in the Journal of Experimental Medicine reports that retinal ganglion cells—neurons in the eye—are rescued by immune cells that infiltrate the mouse retina after eye injury.
A group led by Michal Schwartz at the Weizmann Institute detected immune cells called macrophages in the retinas of mice that sustained eye injuries a few days prior. Thanks to their expression of an anti-inflammatory protein, these macrophages dampened injury-induced inflammation and protected the retinal ganglion cells from death. Macrophage arrival also awakened ...
Spending too much leisure time in front of a TV or computer screen appears to dramatically increase the risk for heart disease and premature death from any cause, perhaps regardless of how much exercise one gets, according to a new study published in the January 18, 2011, issue of the Journal of the American College of Cardiology. Data show that compared to people who spend less than two hours each day on screen-based entertainment like watching TV, using the computer or playing video games, those who devote more than four hours to these activities are more than twice as ...
A team of scientists has created particles that closely mirror some of the key properties of red blood cells, potentially helping pave the way for the development of synthetic blood.
The new discovery – outlined in a study appearing in the online Early Edition of the Proceedings of the National Academy of Sciences during the week of Jan. 10, 2011 – also could lead to more effective treatments for life threatening medical conditions such as cancer.
University of North Carolina at Chapel Hill researchers used technology known as PRINT (Particle Replication in Non-wetting ...
TITLE:
A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma
AUTHOR CONTACT:
Leif Ellisen
Massachusetts General Hospital Cancer Center, Boston, MA, USA
Phone: (617)726-4315; Fax: (617)726-8623; E-mail: ellisen@helix.mgh.harvard.edu
View this article at: http://www.jci.org/articles/view/43897?key=34ca4a64f929de6d5fea
END ...
TITLE:
Generation of hyaline cartilaginous tissue from mouse adult dermal fibroblast culture by defined factors
AUTHOR CONTACT:
Noriyuki Tsumaki
Osaka University Graduate School of Medicine, Suita, UNK, JPN
Phone: +81-6-6879-3552; Fax: +81-6-6879-3559; E-mail: ntsumaki@dbcb.med.osaka-u.ac.jp
View this article at: http://www.jci.org/articles/view/44605?key=631d5aff983c237cf1dc
END ...
EDITOR'S PICK
Cancer cell survival is not miR-ly dependent on p53
Squamous cell carcinoma (SCC) is a common type of skin cancer and remains one of the most resistant to available chemotherapies. Many cancer therapeutic strategies are directed at restoring the function of the tumor suppressor gene p53, because when active, cells are more sensitive to the DNA damage induced by chemotherapy. Other proteins related to p53, including p63 and p73, have also been implicated in cancer and cell sensitivity to chemotherapy. Both p63 and p73 are overexpressed in SCC, and are thought ...
While wealthier people have chosen alternatives to urban nursing homes, the urban poor still depend on them for long-term care. A new study led by researchers at Brown University finds that option is nevertheless slipping away. Between 1999 and 2008, nursing home closures in the United States were concentrated disproportionately in poor, urban and predominantly minority neighborhoods.
Overall, the United States lost 5 percent, or 96,902, of its total nursing home beds during the decade, as patients with means sought assisted living or other forms of home and community-based ...
